GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA

Gesamtdauer:15 h 57 min

	Future of ADCs: Accelerating Progress in Ovarian and Endometrial Cancer	GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA	53:44
	The GOG Highlight Reel – July 2026	GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA	147:28
	Evolving Evidence and Treatment Strategies in Low Grade Serous Ovarian Cancer (LGSOC)	GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA	69:22
	ctDNA-based MRD testing and monitoring in gynecologic cancers	GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA	99:39
	Precision Decision Making in Platinum Resistant Ovarian Cancer: Folate Receptor Alpha Expression and Other Biomarkers Into Contemporary Care	GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA	54:05
	Precision in Endometrial Cancer: Personalized Treatment Strategies for pMMR and dMMR Endometrial Cancer: Charting the Course: Treatment Approaches for dMMR Endometrial Cancer	GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA	19:13
	Evidence Based Biomarker-Driven Advances in Ovarian & Endometrial Cancer: Equitable, Individualized and Accessible Care	GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA	64:52
	Precision in Endometrial Cancer: Personalized Treatment Strategies for pMMR and dMMR Endometrial Cancer First Installment	GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA	87:15
	Beyond the Image: New Opportunities in Gynecologic Cancer Testing	GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA	67:27
	The Long Game in Endometrial Cancer: Interpreting PFS, OS, and the Power of Biomarkers	GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA	84:35
	Global Perspective in Advanced, Recurrent Cervical Cancer: Resources, Opportunities and Access to Care.	GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA	56:06
	From Data to Decisions: Evolving Opportunities in Platinum Resistant Ovarian Cancer	GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA	80:29
	A New Era in Recurrent LGSOC: Incorporating Approved Therapies, Biomarkers, and Clinical Strategies	GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA	73:19